MONTE ROSA THERAPEUTICS INC (GLUE) Stock Balance Sheet
NASDAQ:GLUE • US61225M1027
Current stock price
19.01 USD
-0.28 (-1.45%)
At close:
19.01 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 129.88M | 224.25M | 128.10M | 262.80M | 346.10M | |||
| Marketable Securities | 247.22M | 147.90M | 104.31M | N/A | N/A | |||
| Receivables | 11.60M | 173.00K | 505.00K | 7.70M | N/A | |||
| Other Current Assets | 4.48M | 5.12M | 3.29M | 5.40M | 2.60M | |||
| Total Current Assets | 393.19M | 377.44M | 236.21M | 275.90M | 348.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 50.37M | 56.31M | 62.61M | 61.90M | 12.30M | |||
| Other Non-Current Assets | 5.10M | 4.98M | 4.93M | 4.60M | 5.30M | |||
| Total Non-Current Assets | 55.47M | 61.29M | 67.54M | 66.50M | 17.60M | |||
| TOTAL ASSETS | 448.66M | 438.73M | 303.75M | 342.40M | 366.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 31.09M | 22.50M | 17.76M | 17.70M | 10.10M | |||
| Accounts Payable | 3.55M | 17.21M | 11.15M | 7.90M | 6.60M | |||
| Other Current Liabilities | 29.57M | 117.23M | 17.68M | N/A | 0.00 | |||
| Total Current Liabilities | 64.21M | 156.95M | 46.59M | 25.60M | 16.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 151.39M | 58.85M | 77.91M | 45.40M | 2.20M | |||
| Total Non-Current Liabilities | 151.39M | 58.85M | 77.91M | 45.40M | 2.20M | |||
| TOTAL LIABILITIES | 215.60M | 215.80M | 124.50M | 71.00M | 18.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -477.21M | -438.59M | -365.89M | -230.50M | -122.00M | |||
| Additional Paid In Capital | 714.09M | 664.87M | 547.86M | 503.70M | 471.60M | |||
| Common Shares | 7.00K | 6.00K | 5.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -3.83M | -3.36M | -2.72M | -1.80M | -2.00M | |||
| Shares Outstanding | 65.54M | 61.51M | 50.14M | 49.30M | 46.50M | |||
| Tangible Book Value per Share | 3.56 | 3.62 | 3.58 | 5.51 | 7.47 | |||
| Total Shareholders' Equity | 233.06M | 222.94M | 179.25M | 271.40M | 347.50M | |||
| TOTAL LIABILITIES AND EQUITY | 448.66M | 438.73M | 303.75M | 342.40M | 366.30M | |||
| Statistics | ||||||||
| Current Ratio | 6.12 | 2.40 | 5.07 | 10.78 | 21.01 | |||
| Return On Assets (ROA) | -8.61% | -16.57% | -44.56% | -31.69% | -20.19% | |||
| Return On Equity (ROE) | -16.57% | -32.61% | -75.51% | -39.98% | -21.28% | |||
All data in USD , ROIC based on taxRate of 0.21